submitted
[용어속성] Action
Numbers, graphs and words – do we really understand the lab test results accessible via the patient portals?
Original Research Article
[키워드] Affect
asked
Care
Care seeking
Community
contribute
Course
COVID-19
effective
electronic patient record
EPR
expressions
Follow-up
Health
Health information technology
healthcare
highlighting
hospital
hypothetical
implication
include
information
Information format
Internet
lab
layperson
locus
participant
Participants
Patient
Patient care
patient engagement
personal health
Policy
questionnaire
reaction
recommendation
required
response
responses
Result
submitted
the patient
understanding
urgency
verbal
[DOI] 10.1186/s13584-020-00415-z PMC 바로가기 [Article Type] Original Research Article
[DOI] 10.1186/s13584-020-00415-z PMC 바로가기 [Article Type] Original Research Article
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
24 hour
Ability
absence
accompany
activity
Administered
administration
Admission
adverse events
Affect
age
alkaline phosphatase
allergy
ALT
alternative hypothesis
ambient
Analysis
ANC
Anti-inflammatory
anticipated
antipyretics
antivirals
Arm
ARMS
assumed
AST
Baltimore
baseline
benefit
blinded
block
block randomization
Blood
breastfeeding women
Bronchoalveolar lavage
calculated
Care
Cellulose
center
Chest
chest X-ray
childbearing potential
clinical
clinical condition
Clinical course
clinical impact
Clinical improvement
Clinical outcome
clinical status
clinical trial
collected
competing
Compliance
concealed
Concentration
Concomitant
conditions
conducted
congestive heart failure
Contraception
Control
control arm
Conventional
Corticosteroids
COVID-19
COVID-19 disease
COVID-19 infection
COVID-19 pandemic
criteria
criterion
Critical
CT scan
current
Day
Declaration of Helsinki
decrease
defined
detect
direct bilirubin
disease
disorder
dissemination
dose
double-blind
drug
Drug administration
drug-drug interaction
drugs
Duration
ECMO
Efficacy
Efficacy and safety
element
eligible
endosomal pH
Enrollment
ethnic group
evaluate
Evidence
exclusion
expected
exploratory endpoint
extracorporeal membrane oxygenation
Face mask
FDA
Fisher
Good
group
handling
harmonization
hematologic
histocompatibility complex
Hospitalization
Hospitalized
hospitalized patient
Hydroxychloroquine
Hypothesis
ICU
IL-6 levels
Imatinib
immunomodulatory
immunomodulatory drugs
IND
information
Informed consent
inhibitory activity
intensive care
intensive care unit
intention to treat
interfere
International Conference
invasive
Invasive mechanical ventilation
investigational agent
investigator
ITT
Laboratory
Last
limit
limitation
liver
Local
lysosomal sequestration
magnitude
matching placebo
mechanical ventilation
men and women
MHC
mononuclear cell
Mortality
nasal
nasopharyngeal
Nasopharyngeal swab
neutrophil count
New
new oxygen use
non-invasive ventilation
non-rebreather mask
not blinded
null hypothesis
number
objective
off-label
off-label use
Oropharyngeal
outcome
outcomes
oxygen
Oxygenation
P450
packaged
PaO
participant
Participants
Patient
patients
patients with ARDS
patients with COVID-19
PBMCs
performed
Pharmacist
Pharmacy
phase 3 study
Placebo
placebo-controlled
Pneumonia
positive COVID-19
Practice
primary analysis
primary endpoint
principal
progression
proportion
protocol
Psychiatric
Radiographic
random number generator
randomised controlled trial
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
Regulatory
renal dysfunction
renal replacement therapy
replication of SARS-CoV-2
required
requiring supplemental oxygen
Respiratory illness
respiratory tract
risk
RT-PCR
Safety
Sample size
sarilumab
SARS-CoV
SARS-CoV-2
secondary endpoint
Seizure
Serious Adverse Events
service
severe disease
severity
significance level
Site
Society
stability
Standard of care
status
stratified
study drug
study enrollment
study outcomes
Study protocol
subject
submitted
supplemental oxygen
Support
Suspension
symptomatic
Tablet
temperature
Test
the patient
the primary endpoint
time
TKI
TKI-induced attenuation of vascular leak
TKI-induced prevention and treatment lung inflammation
Tocilizumab
transcriptomics
Treatment
treatment allocation
treatment arm
treatments for COVID-19
Trial
two-sided
tyrosine kinase inhibitor
uncontrolled
university
unstable angina
vasopressors
ventilator
ventilator free days
viral ABL-1 signalling
website
with COVID-19
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
accompany
addition
adverse effect
Asymptomatic
Asymptomatic COVID-19
baseline
blinded
breathlessness
bronchial asthma
calculated
carried
Chain Reaction
changes in
Chennai
clinical
clinical assessment
clinical trial
co-morbidity
college
control group
cough
COVID
COVID-19
CTRI
Data analysis
determine
Diabetes Mellitus
dissemination
dose
Efficacy
element
eligibility assessment
evaluate
excluded
exploratory
Factor
Fever
filtered
Herbal decoction
hypertension
IFNγ
IL10
IL2
Immunity
immunological
independent
India
information
investigator
involved
lactating
malignancy
management
marker
Medicine
Microsoft Excel
number
objective
Occurrence
onset of symptom
Open-label
outcome
parallel group
participant
positive
pregnant
Primary outcome
progression
protocol
random number generation
randomised
randomised controlled trial
randomization
Randomized controlled trial
receive
recruit
recruited
recruitment
reduced
reducing
reduction
reduction in
Registered
reported
RT-PCR
Sample
Sample size
SARS-CoV-2 viral load
sealed
Secondary outcomes
severe respiratory disease
Siddha
Siddha Medicine
Standard
state
Study protocol
submitted
Symptom
symptomatic
Tablet
tested
the SARS-CoV-2
threshold
TNF
traditional methods
Treatment
Trial
Tumor
Vitamin
website
Zinc
[DOI] 10.1186/s13063-020-04823-z PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04823-z PMC 바로가기 [Article Type] Letter
COVID-19 myocarditis: a case report
Case Report
[키워드] acute respiratory syndrome
Admission
Cardiomiopatias
Cardiomyopathies
Case report
communicable diseases
Coronavírus
coronavirus
coronavirus disease
Coronavirus infections
COVID-19
Diagnosis
Doenças Transmissíveis
dysfunction
echocardiography
Ecocardiografia
flu-like symptom
Infecções por coronavírus
infecção
Laboratory
magnetic resonance imaging
male
manifestation
Miocardite
myocarditis
Patient
Pneumonia
reported
Síndrome Respiratória Aguda Grave
Severe acute respiratory syndrome
submitted
Tomografia computadorizada por raios X
tomography
Tomography, X-Ray Computed
[DOI] 10.31744/einstein_journal/2020RC5876 PMC 바로가기 [Article Type] Case Report
[DOI] 10.31744/einstein_journal/2020RC5876 PMC 바로가기 [Article Type] Case Report
The Strange Case of BCG and COVID-19: The Verdict Is Still up in the Air
Perspective
[키워드] absence
approach
articles
BCG
BCG vaccination
caused
children
conditions
confounding factor
contribute
correlation
country
COVID-19
COVID-19 case
drug
elicit
Evidence
Germany
help
highlight
Human
immune response
infections
medRxiv
Miller
morbidity and mortality
National
Netherlands
non-specific
Novel coronavirus
pandemic
passive immunity
PROTECT
protective effect
provided
reducing mortality
SARS-CoV-2
shown
significantly
Still
submitted
trained immunity
Trial
Tuberculosis
vaccination
Vaccine
widespread
[DOI] 10.3390/vaccines8040612 PMC 바로가기 [Article Type] Perspective
[DOI] 10.3390/vaccines8040612 PMC 바로가기 [Article Type] Perspective
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
입원한 COVID-19 환자의 결과 개선에 대한 파모티딘의 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] Alanine
Alanine transaminase
alcoholism
All participant
All participants
allergies
allergy
allocation
approved
ARMS
aspartate
Aspartate transaminase
assigned
assumption
Bandar Abba
Bandar Abbas
baseline
Blinding
block randomization
blood count
Care
Chronic kidney disease
clearance
clinical
clinical trial
clinical trials
code
Committee
company
comparator
Comparator group
complete blood count
concealed
control group
control groups
COVID-19
COVID-19 patient
COVID-19 patients
creatinine
creatinine clearance
criteria
Dasatinib
dialysis
discharge
dissemination
dosage
drug therapy
electrocardiogram
element
eligibility criteria
End-stage renal disease
ethics committee
Evidence
evidence of
excluded
expected
Famotidine
G6PD
Glucose
Glucose 6 phosphate
grouping
groups
Hepatitis
hepatitis C
Hospitalized
Immunocompromised
Immunocompromised patients
Infection
Intervention
Kidney disease
Lactate
lactate dehydrogenase
lead
limit
Liver disease
Local
lung infiltration
maximum
Medical Science
Medical Sciences
moderate
need for dialysis
Neratinib
normal limit
number
objective
online tool
oral contraceptives
outcome
outcome assessor
outcome assessors
oxygen
oxygen saturation
Ozanimod
participant
Patient
patients
patients with COVID-19
Pazopanib
PCR test
pharmaceutical
Pharmaceutical Company
phosphate
Placebo
placebo-controlled
porphyria
positive
Pregnancy
protocol
psoriasis
random
randomisation
randomised
randomised controlled trial
randomized clinical trial
Randomly
randomly divided
receive
recruitment
Registered
registry
renal
renal disease
renal failure
reported
Research question
researcher
respiration rate
responsible
Rilpivirine
Sample size
sample size calculation
sequence
sequence information
single-blind
Siponimod
Standard
study drug
Study protocol
subject
submitted
technology
temperature
the ethics committee
therapy
title
Tizanidine
transaminase
Treatment
treatment group
Treatment protocol
treatment protocols
Trial registration
two group
two groups
university
Version
website
were measured
written consent
[DOI] 10.1186/s13063-020-04773-6 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04773-6 PMC 바로가기 [Article Type] Letter
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)
증상이 있는 SARS-CoV-2 감염(COVID-19)이 있는 고령자의 가정 치료: 여러 가지 실험적 치료의 효능과 내약성을 평가하기 위한 MAMS(Multi-Arm Multi-Stage) 무작위 시험에 대한 연구 프로토콜의 구조화된 요약 65세 이상 외래 환자의 입원 또는 사망 위험 감소(COVERAGE 시험)
Letter
[키워드] 6-mercaptopurine
Abnormalities
ACEi
added
age
amodiaquine
Analysis
antrafenine
approved
ARB
ARBs
Arm
azathioprine
Blinding
Bordeaux
Caregivers
Chloroquine
chronic hepatitis
Chronic kidney disease
citalopram
clinical
Colitis
Combination
comparator
complex
conducted
Control
control arm
COVID-19
COVID-19 pandemic
criteria
CYP3A4
cytochrome P450
Dasatinib
death
Dementia
dialysis
dissemination
Domperidone
drug
Duchy
Efficacy
element
enrolled
enrolment
Enterocolitis
escitalopram
EudraCT
Evidence
exclusion criteria
experimental arm
experimental drug
Experimental drugs
Favipiravir
feasibility
Final
final analysis
first symptom
first symptoms
floctafenine
France
French
futility
galactose
GFR
glafenine
Glucose
Glucose-6-phosphate
glucose-6-phosphate dehydrogenase
glucose-6-phosphate dehydrogenase deficiency
Grand duchy
halofantrine
Health Insurance
heart rate
hepatic
Hepatic porphyria
home
hospital
hospitalisation
Hydroxychloroquine
hydroxyzine
hypersensitivity
Hyperuricemia
Ileus
Imatinib
immunological
incidence
Inclusion
increase in
inducer
inhibitor
Interim analyses
interim analysis
intervals
investigator
investigators
Isoenzyme
Kidney disease
Lactase
Lactose
liver failure
Long
Long QT syndrome
Luxembourg
malabsorption
mefloquine
mercaptopurine
metabolism
multi
multi-arm
nasopharyngeal
Nasopharyngeal swab
New
Nilotinib
not blinded
number
nursing home
nursing homes
objective
Older
Open-label
open-label trial
other treatment
other treatments
outcome
Outpatient
P450
Paris
participant
Patient
performed
phase
Piperaquine
Positive test
Prevent
primary care
Primary outcome
proportion
protocol
pyrazinamide
QTc interval
randomisation
randomised
Randomized
Randomly
receive
recruited
Region
Registered
regulatory authority
repaglinide
replaced
REPLACED BY
reported
Repurposed drug
residence
Safety Monitoring Board
Sample size
SARS-CoV-2
SARS-COV-2 infection
scale
Stage
Standard
statistician
statisticians
status
stratified
Study protocol
submitted
symptomatic SARS-CoV-2 infection
Tablet
telmisartan
tested
theophylline
Toxicity
Trace element
trace elements
treated
Treatment
treatment arm
Trial
Trial registration
Version
virus
Virus Disease
Vitamin
vitamins
Warfarin
[DOI] 10.1186/s13063-020-04619-1 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04619-1 PMC 바로가기 [Article Type] Letter
Impact of novel coronavirus disease (COVID-19) on Egyptian dentists’ fear and dental practice (a cross-sectional survey)
Article
[키워드] analyzed
CDC
collected
Control
coronavirus disease
COVID-19
COVID-19 pandemic
Cross-infection
cross-sectional survey
Dental epidemiology
dentist
evaluate
Impact
infected with COVID-19
Infection
knowledge
majority
Modification
novel coronavirus disease
objective
occupational health
pandemic
participant
Patient
prevention
professional
professionals
questionnaire
Result
statistically
submitted
Symptoms
Transmission
treat
virus
WHO
World Health Organization
[DOI] 10.1038/s41405-020-00047-0 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41405-020-00047-0 PMC 바로가기 [Article Type] Article
Abdominal symptoms as initial manifestation of COVID-19: a case series
Case Report
[키워드] Abdome/diagnóstico por imagem
Abdomen/diagnostic imaging
affected
Atypical
base
bases
carried
case sery
change
Chest
Chest computed tomography
Computed tomography
Computed tomography, X-ray computed
Coronavirus infections
Course
COVID-19
Gastroenteropatias/diagnóstico por imagem
Gastrointestinal diseases/diagnostic imaging
gastrointestinal involvement
Gastrointestinal symptom
gastrointestinal symptoms
imperative
Infecções por coronavírus
initial
Local
lung
manifestation
manifested
New coronavirus
new virus
occur
Pandemia
pandemic
Patient
polymerase chain
positive
produced
prognostic
pulmonary involvement
radiologist
Radiologists
reported
significant changes in
submitted
Symptom
Symptoms
Tórax/diagnóstico por imagem
the disease
the patient
Thorax/diagnostic imaging
Tomografia computadorizada por raios X
tomography
[DOI] 10.31744/einstein_journal/2020RC5831 PMC 바로가기 [Article Type] Case Report
[DOI] 10.31744/einstein_journal/2020RC5831 PMC 바로가기 [Article Type] Case Report